Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth.
about
Extracellular vesicle-mediated transport of non-coding RNAs between stem cells and cancer cells: implications in tumor progression and therapeutic resistance.RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.Molecular Determinants of Malignant Brain Cancers: From Intracellular Alterations to Invasion Mediated by Extracellular Vesicles.High-throughput screening uncovers miRNAs enhancing glioblastoma cell susceptibility to tyrosine kinase inhibitors.Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.
P2860
Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth.
@en
type
label
Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth.
@en
prefLabel
Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth.
@en
P2093
P2860
P356
P1476
Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth.
@en
P2093
Denys Fontaine
Fabien Almairac
Fanny Burel-Vandenbos
Laurent Turchi
Marie-Pierre Junier
Philippe Paquis
Sandra Lacas-Gervais
Thierry Virolle
P2860
P2888
P356
10.1038/CDDIS.2017.117
P577
2017-03-30T00:00:00Z
P6179
1084127839